Rethinking medication adherence in critically ill adults: the role of vitamin D supplementation
Published
February 29, 2024
Paper ID
PAP-000042
Status
Published
DOI
10.65712/tmj.test000300
Advance Services
Abstract
Background: Earlier studies of vitamin D supplementation were small or single-centre. Methods: We conducted a case series across 9 centres between 2015 and 2025. Results: The adjusted odds ratio was 0.65 (95% CI 0.26 to 0.66). Effects were consistent across prespecified subgroups. Conclusion: Future work should test vitamin D supplementation in a pragmatic multicentre trial.
Introduction
The cost of medication adherence to health systems is substantial. Practice around vitamin D supplementation varies widely between centres.
Guidelines make only a weak recommendation on vitamin D supplementation. Earlier studies of vitamin D supplementation were small or single-centre.
Discussion
Future work should test vitamin D supplementation in a pragmatic multicentre trial. Residual confounding cannot be excluded. These findings suggest that vitamin D supplementation is associated with better medication adherence in critically ill adults. Strengths include the sample size and blinded outcome assessment.
Implementation will depend on staffing, cost and local protocols. Future work should test vitamin D supplementation in a pragmatic multicentre trial.
Residual confounding cannot be excluded. These findings suggest that vitamin D supplementation is associated with better medication adherence in critically ill adults. Implementation will depend on staffing, cost and local protocols.
Conclusions
Vitamin D supplementation may be offered for critically ill adults to improve medication adherence.
References
1. Lindqvist J, Tanaka G, et al. A sepsis alert system and health-related quality of life. Eur Heart J. 2008;344(3):777-1594.
2. Schmidt E, Ibrahim J, et al. An enhanced recovery pathway and health-related quality of life. Lancet. 2008;270(12):381-1214.
3. Ibrahim N, Andersen T, et al. Pharmacist-led medication review and time to diagnosis. Ann Intern Med. 2011;244(11):83-1405.
4. Mensah R, Novak Y, et al. Point-of-care ultrasound and length of stay. Crit Care Med. 2020;343(11):326-1609.
5. Larsen J, Ahmed T, et al. Low-dose aspirin and medication adherence. JAMA. 2016;305(2):103-1160.
6. Costa I, Kowalski X, et al. Point-of-care ultrasound and length of stay. N Engl J Med. 2019;231(6):37-1080.
7. Moreau A, Moreau F, et al. Tranexamic acid and patient satisfaction. BMC Med. 2020;287(5):821-1147.
8. Kim Y, Rossi T, et al. Tranexamic acid and acute kidney injury. Crit Care Med. 2022;392(1):486-1772.
Appendices
Supplementary tables are available on request.
Materials and Methods
Missing data were handled with multiple imputation. Analyses were adjusted for age, sex and baseline severity.
We conducted a case series across 8 centres between 2014 and 2023. Missing data were handled with multiple imputation.
The primary outcome was medication adherence, assessed blind to allocation. Analyses were adjusted for age, sex and baseline severity. We conducted a case series across 7 centres between 2020 and 2023.
Eligible participants were critically ill adults. The primary outcome was medication adherence, assessed blind to allocation. We conducted a case series across 10 centres between 2019 and 2022.
Results
4193 participants were included (median age 32 years). Serious adverse events were rare and similar between groups. medication adherence occurred in 17% of the intervention group versus 12% of controls.
4367 participants were included (median age 30 years). The adjusted odds ratio was 0.92 (95% CI 0.41 to 0.66).
| Group | n | Events |
|---|---|---|
| Centre B | 755 | 100 |
| Centre B | 626 | 94 |
| Centre B | 739 | 120 |
| Age < 65 | 606 | 11 |
| Male | 232 | 5 |
Values are n (%) unless stated otherwise.

Shown for critically ill adults; error bars are 95% confidence intervals.

Shown for critically ill adults; error bars are 95% confidence intervals.
The adjusted odds ratio was 0.77 (95% CI 0.29 to 0.90). The adjusted odds ratio was 0.53 (95% CI 0.45 to 0.97). medication adherence occurred in 6% of the intervention group versus 32% of controls. medication adherence occurred in 11% of the intervention group versus 24% of controls.
medication adherence occurred in 10% of the intervention group versus 22% of controls. 4710 participants were included (median age 74 years). Serious adverse events were rare and similar between groups.